MONDAY, Nov. 14, 2022 (HealthDay News) — The EpiPen is a known lifesaver when someone with a serious food allergy eats something they can’t tolerate. Yet the auto-injection treatment is greatly underused in the United States, according to a new survey. Just over half of at-risk adults said they hadContinue Reading
MONDAY, Nov. 14, 2022 (HealthDay News) – Colorado voters have voted narrowly to approve the medical use of “magic mushrooms” in Colorado. “I’m in awe of what we were able to accomplish,” said Veronica Lightning Horse Perez, a lead proponent for legalizing psilocybin, the main psychoactive compound in mushrooms. “OverContinue Reading
FRIDAY, Nov. 11, 2022 (HealthDay News) — COVID-19 swept across the world far more effectively than previously thought, with a stunning number of cases left unreported as recently as the summer of 2021, a new World Health Organization (WHO) study says. About 3 out of every 5 human beings carriedContinue Reading
THURSDAY, Nov. 10, 2022 (HealthDay News) — When people with heart failure wind up in the hospital, it tends to become a slippery slope: They are more likely to be readmitted or die within six months during this vulnerable period. Now, new research shows that ramping up doses of threeContinue Reading
THURSDAY, Nov. 10, 2022 (HealthDay News) – Getting vaccinated for COVID-19 while pregnant provides higher levels of antibodies for both mom and baby than catching the virus does, a new study finds. When pregnant women received one of the two available mRNA vaccines, researchers found that the women had 10-foldContinue Reading
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — The U.S. opioid epidemic has been heartbreaking — literally. Young adults’ risk of dying from a devastating infection of the heart has doubled to tripled in the United States during the past two decades, a new study reports. Researchers ascribe the increase inContinue Reading
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Tuesday warned health care workers to look out for patients who may have been exposed to a potentially deadly animal sedative, possibly through illicit drug use. The veterinary medication xylazine is sometimes added to fentanyl, heroinContinue Reading
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — More American youth than ever are so addicted to e-cigarettes that they vape within 5 minutes of waking up in the morning, a new analysis shows. While that percentage was around just 1% in 2017, it increased every year after that. It reachedContinue Reading
TUESDAY, Nov. 8, 2022 (HealthDay News) — More and more nervous patients are showing up stoned for dental appointments, often forcing dentists to postpone treatment until the patient sobers up, new survey data shows. As more states are legalizing marijuana, more than half of dentists (52%) report seeing patients highContinue Reading
TUESDAY, Nov. 8, 2022 (HealthDay News) – Some patients with high blood pressure can’t get it under control with standard medications, but a new study shows an experimental drug is up to the task of treating these tough-to-treat cases. Why do some folks struggle more with managing their high bloodContinue Reading
TUESDAY, Nov. 8, 2022 (HealthDay News) — Patients with heart failure are often prescribed a diuretic or “water pill” to prevent fluid buildup. A new study has found that two often-prescribed medications work equally well at reducing deaths. “Given that the two different therapies provide the same effect on outcomes,Continue Reading
MONDAY, Nov. 7, 2022 (HealthDay News) — Infants and children sick with RSV are flooding pediatricians’ offices and children’s hospitals across the United States, due to an early surge of the common childhood virus this year. But within one or two “sick seasons,” doctors expect to have on hand long-soughtContinue Reading
MONDAY, Nov. 7, 2022 (HealthDay News) — The antiviral pill Paxlovid not only reduces hospitalization and death after catching COVID-19: New research shows it also cuts the chances of long COVID by roughly 25%. The drug, which combines a newer antiviral called nirmatrelvir with an older medication known as ritonavir,Continue Reading
FRIDAY, Nov. 4, 2022 (HealthDay News) — Getting an updated booster for COVID-19 is likely to boost protection substantially, according to a new study released by drug company Pfizer on Friday. The news affirms a decision by the U.S. Food and Drug Administration to OK the bivalent booster without firstContinue Reading